- Joined
- May 21, 2006
- Posts
- 4
- Reactions
- 0
This company looks poked. Down from a $1.80 to $1.12 in the last 2 months. Revenues and profits have declined over three successive years and management have no plan to arrest the decline.
Correct me if I am wrong. I think the value of the asset transferred from Pfizer does not show up in IDT's asset. It is still Pfizer's even though it is developed and located in IDT's compound. Pfizer is only letting IDT to make use of the asset and share the profit generated by it.Didn't these guys become redundant whent they lost that contract with Pfizer a few years ago. Pfizer even gave them several million dollars worth of equipment, iirc. Looking at the BS, if they stopped trading and wound up the company they'd probably create shareholder value! The again, there biggest asset is a piece of redundant PP&E given to them, so you have to wonder if it's really worth it's BV.
Thread starter | Similar threads | Forum | Replies | Date |
---|---|---|---|---|
![]() |
Futures broker Australia | Brokers | 0 | |
![]() |
SLK - SILK Laser Australia | Stocks Q-Z | 0 | |
![]() |
Cannabis products access opening up via TGA Australia & EU | ASX Stock Chat | 29 | |
D | How to open IBKR Lite in Australia | Stock Market Nuts and Bolts | 3 |
Hello and welcome to Aussie Stock Forums!
To gain full access you must register. Registration is free and takes only a few seconds to complete.
Already a member? Log in here.